A Multi-Center Study Evaluating the Safety of AC-170 0.24%

Clinical trial NCT02132169 · COMPLETED

Trial details

NCT number: NCT02132169
Sponsor: Aciex Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Disease (Including Allergic Conjunctivitis)

Start date: 2014-05-01
Primary completion: 2014-10-01
Enrollment: 512

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.